Difference between revisions of "Obinutuzumab (GA101)"
Jump to navigation
Jump to search
(Created page with "'''In clinical trials'''. Also known as RO5072759, Afutuzumab. ==General information== Class/mechanism: Glyco-engineered anti-CD20 IgG1 type II monoclonal antibody. Engineered...") |
m (Redirected page to Obinutuzumab (Gazyva)) |
||
(4 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
− | + | #REDIRECT [[Obinutuzumab (Gazyva)]] | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− |
Latest revision as of 13:10, 18 December 2013
Redirect to: